Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration on Thursday imposed new tariffs on brand-name drugs from pharmaceutical companies that have not reached agreements with…
Regeneron Pharmaceuticals Inc.
AstraZeneca shares rise after surprise lung disease trial win
AstraZenecaShares rose more than 3% after Britain's most valuable company said its experimental drug for lung diseases met its target…
How CNBC Cures is bringing rare disease stories to a national audience
Last summer, my sister Becky approached me with an idea. He wanted my help to build a platform on CNBC…
FDA Vaccine Director to Resign in April After Series of Controversial Decisions
The Food and Drug Administration logo before a news conference at Health and Human Services Headquarters in Washington, April 22,…
Another Alliance Between Healthcare and AI Indicates Why Pharma Stocks Could Make a Comeback
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating the early detection of lung cancer marks the latest way…
Trump asks drug manufacturers to reduce prices in 60 days
The president of the United States, Donald Trump, the Secretary of Human Services and Health of the United States (HHS),…
Chinese obesity can become a rival of Eli Lilly Zepbound
Cr | Istock | Getty images A version of this article appeared for the first time in the Healthy Bulletin…
Anne Wojcicki will buy 23 Andme and her data for $ 305 million
The founder of 23Andme, Anne Wojcicki, speaks during a supervision committee of the Government Supervision and Reform Chamber in Washington,…
The best selections of Biotechnology and Farma by JPMorgan for the second half
The low performance of biopharmaceutical actions versus the widest market for a third consecutive year is an opportunity for investors,…
Regeneron Pharmaceuticals to buy 23andme and their data for $ 256 million
A view of the 23ndme headquarters in Sunnyvale, California, on March 25, 2025. Tayfun Coskun | Anadolu | Getty images…